author-photo

Tanja Trarbach

University of Duisburg-Essen

81

Papers

2282

Citations

Citation Trend

Filter By

Papers (81) Sort By

JournalConferenceOthers

Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer: Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.

2021 Radiation Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Biweekly Cetuximab plus FOLFOX6 as first-line therapy in patients with RAS wild-type metastatic colorectal cancer – the CEBIFOX trial

2020 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (1)
438P Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer: The RAMTAS trial of the German AIO

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Molecular dissection of effector mechanisms of RAS -mediated resistance to anti-EGFR antibody therapy

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
Gemcitabine and oxaliplatin (GEMOX) alone or with cetuximab in first-line treatment of advanced biliary cancers (ABC): Exploratory analyses according to tumor KRAS/BRAF mutations and EGFR expression in a randomized phase II trial (BINGO).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

2017 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (11)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号